CoVacHGMix
/ Scientific and Technological Research Council of Turkey
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 02, 2022
Phase I Clinical Trial With New SARS-CoV-2 CoVacHGMix Type 5 Adenoviral Vector Vaccine
(clinicaltrials.gov)
- P1 | N=36 | Recruiting | Sponsor: Ankara City Hospital Bilkent
New P1 trial • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
1 to 1
Of
1
Go to page
1